ZDHHC3 further exhibited promoted effects on NASH progression by activating IRHOM2 and its downstream MAP3K7‐JNK cascade signaling, thereby increasing hepatosteatosis, inflammation, and collagen accumulation. The gene discussed is RHBDF2; the disease is metabolic dysfunction-associated steatohepatitis.